Home Perchlorate (Irenat®) may falsely lower measured ionised calcium
Article
Licensed
Unlicensed Requires Authentication

Perchlorate (Irenat®) may falsely lower measured ionised calcium

  • Michael Gruber EMAIL logo , Carsten Nehring , Marcus Creutzenberg , Bernhard Graf and Susanne Hopf
Published/Copyright: March 24, 2011

Abstract

Background: Discrepancies in ionised calcium concentrations between results from several point-of-care devices derived from intensive care unit (ICU) patients were postulated to be caused by perchlorate, a thyroid blocking agent. The deviations were serious concerning the diagnosis of hyper- or hypocalcaemia and administration of calcium infusions.

Methods: The problem was studied from three perspectives. First: quantification of ionised calcium in heparinised blood samples spiked with sodium perchlorate from healthy volunteers measured using five blood gas analysers (BGAs from IL, Radiometer, Roche and Siemens). Second: verification of clinical concentrations of perchlorate in blood samples after routine use for blood gas analysis from ICU patients. Third: retrospective analysis of data stored from patients during their stay in general ICU of the Departments of Anesthesio-logy and General Surgery by a patient data management system.

Results: Category 1: three of the point-of-care testing devices measure clinically relevant falsely low ionised calcium concentrations when exposed to concentrations perchlorate >0.1 mmol/L. Two were not able to identify hypercalcaemia of up to 4 mmol/L ionised calcium when specific perchlorate concentrations are exceeded. Category 2: measured clinical concentrations of perchlorate ranged between the lower limit of quantification [LOQ=0.03 mmol/L and 2.75 mmol/L (median=0.29 mmol/L; mean=0.585 mmol/L)]. A concentration above 0.1 mmol/L perchlorate was found in 74.3% of all samples that tested positive. Category 3: between February 2006 and July 2009, 42 patients per year (2.2%) received sodium perchlorate with a median length of treatment of 25 days.

Conclusions: Perchlorate causes clinically relevant lowering of measured ionised calcium in BGAs from two providers at concentrations obtained in samples from ICU patients (affecting about 1.1% of all ICU patients).


Corresponding author: Michael Gruber, Klinik für Anaesthesiologie der Uniklinik Regensburg, Franz-Josef-Strauss-Allee 11, 93042 Regensburg, Germany Phone: +49-941-944-7870, Fax: +49-941-944-7802

Received: 2010-11-10
Accepted: 2011-1-6
Published Online: 2011-03-24
Published in Print: 2011-06-01

©2011 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Editors’ and Publisher’s Note
  2. CCLM Award for The Most Cited Paper Recently Published
  3. Reviews
  4. Some views on proteomics in diabetes
  5. Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics
  6. Minireviews
  7. Low-density lipoprotein receptor-related protein 1: new functions for an old molecule
  8. Could serum measurements of S100 proteins be reliable markers to predict recurrence in meningiomas?
  9. Opinion Paper
  10. Focusing on the clinical impact of standardization of creatinine measurements: a report by the EFCC Working Group on Creatinine Standardization
  11. General Clinical Chemistry and Laboratory Medicine
  12. Use of a fully automated immunoassay for celiac disease screening in a pediatric population
  13. Evaluation of four commercial biuret reagent kits of serum total protein by the American Association for Clinical Chemistry reference measurement procedure
  14. Renal function parameters during early and late recovery periods following an all-out 21-km run in trained adolescent runners
  15. Increased urinary neutrophil gelatinase associated lipocalin in urinary tract infections and leukocyturia
  16. The severity of pseudohyperkalaemia is not dependent upon the stage of chronic kidney disease: a prospective study
  17. Modified phosphatidylserine-dependent antithrombin ELISA enables identification of patients negative for other antiphospholipid antibodies and also detects low avidity antibodies
  18. Perchlorate (Irenat®) may falsely lower measured ionised calcium
  19. Comparison of thyroglobulin antibody interference in first- and second-generation thyroglobulin immunoassays
  20. A case of consistent discrepancies between urine and blood human chorionic gonadotropin measurements
  21. Reference Values and Biological Variations
  22. Reference change values for monitoring dehydration
  23. Cancer Diagnostics
  24. Diagnostic value of pro-gastrin-releasing peptide for small cell lung cancer: a meta-analysis
  25. Plasma concentrations of angiogenetic factors and angiogenetic inhibitors in patients with ductal pancreatic neoplasms. A pilot study
  26. Cardiovascular Diseases
  27. High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC Study
  28. Letters to the Editor
  29. Results of a pilot external quality assessment study on free protoporphyrin in erythrocytes
  30. Trueness assessment of Korean nation-wide glucose proficiency testing
  31. Genetic polymorphism of cytochrome P450 1A1 in a northern Italian population: high frequency of the CYP1A1*2C allele
  32. Prestaining of PCR products with SYBR Green for agarose gel electrophoresis: advantages and limitations
  33. A bias in quantitative RT-PCR limit of detection is induced by the use of cancer cell lines in the molecular detection of circulating tumor cells
  34. Treatment of hepatitis B virus-associated membranous nephritis patients in Chinese: an open parallel controlled trial
  35. Evidence on the cause of false positive troponin I results with the Beckman AccuTnI method
  36. Cross-reactivity of insulin analogs with the Diasorin Liaison Insulin assay
  37. Improved turnaround time for neonatal hematology profile tests (complete blood count) using a new microcollection tube
  38. Erratum
  39. Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2011.160/html
Scroll to top button